Washington, D.C. (PRWEB) June 18, 2012
The Pharmaceutical Research and Manufacturers of America (PhRMA) announced today the election of Johnson & Johnson Pharmaceuticals Group Worldwide Chairman Joaquin Duato and AstraZeneca Global Commercial Executive Vice President Tony Zook to its Board of Directors.
“We are pleased to welcome two industry veterans – Mr. Duato and Mr. Zook – to PhRMA’s Board of Directors,” said PhRMA President and CEO John J. Castellani. “As we continue to advocate for innovation and patient-centered policies in the U.S. and around the world, PhRMA and its membership will undoubtedly benefit from these leaders’ keen insights and deep knowledge of our sector.”
Mr. Duato is Worldwide Chairman, Pharmaceuticals Group, at Johnson & Johnson. In this role, he is responsible for the company’s global pharmaceutical commercial businesses and the Operations, Quality and Compliance functional groups that support the commercial and research and development organizations. In addition, Mr. Duato leads the company’s Pharmaceuticals Group Operating Committee.
“The biopharmaceutical industry is vital to improving health and saving lives and I feel privileged to join this dynamic board in helping the industry continue to play a critical role in transforming the lives of patients and contributing strongly to the U.S. economy,” said Mr. Duato.
A native of Valencia, Spain, Mr. Duato holds an undergraduate degree in Economics and two Master’s degrees – one in Business Administration from ESADE in Barcelona and the other in International Management from Thunderbird in Phoenix, Arizona.
Mr. Zook is the Executive Vice President of AstraZeneca’s Global Commercial organization, accountable for worldwide marketing and sales activities, as well as central commercial capabilities and strategies that support those efforts. The global marketing and sales business guides the development and leads the strategic marketing of prescription drugs designed to improve the health and quality of life of patients around the world.
“It is an honor to join the board of an organization deeply committed to helping patients access the medicines they need and fostering medical innovation,” said Mr. Zook. “I look forward to working closely with John Castellani and the board during this challenging, yet exciting time in the industry’s evolution.”
Prior to this role, Mr. Zook directed AstraZeneca’s largest market – North America – and headed the company’s Global Marketing function. He was also President of AstraZeneca’s biologics business MedImmune. He earned a Bachelor's Degree in Biology from Frostburg University and an Associate's Degree in Chemical Engineering from Pennsylvania State University.
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $49.5 billion in 2011 in discovering and developing new medicines.
Find PhRMA Online: